Founders Fund Growth Management, LLC

In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), Founders Fund Growth Management, LLC reported 3 stock positions worth $32.7 million. Its top holding was Affirm (AFRM) at 95.6% of the portfolio, followed by Abcellera Biologics (ABCL, 3.7%) and Opendoor Technologies (OPEN, 0.7%). Compared with Q1 2024, it reduced 1. The biggest sale was Affirm (AFRM, shares −36%).

Most Recent 13F
Q4 2025
Location
SAN FRANCISCO, CA
CIK
0001853431
Portfolio Value
$32.7M (Q2 2024)
SEC Filing
0001085146-24-003979 ↗ filed Aug 14, 2024

Holdings Value

0$20.0M$40.0M$60.0M$80.0M Q1 2024: $62.7M Q1 2024 Q2 2024: $32.7M $32.7M Q2 2024 Q3 2024: $1.1M Q3 2024 Q4 2024: $200K Q4 2024 Q1 2025: $128K Q1 2025 Q2 2025: $66K Q2 2025 Q3 2025: $75.3M Q3 2025 Q4 2025: $7.0M Q4 2025

Holdings 3 stocks · $32.7M
AFRM Affirm Holdings Inc. 95.61% 1,034,838 $31.3M Reduce -36.2%
ABCL Abcellera Biologics Inc. 3.68% 407,017 $1.2M No change
OPEN Opendoor Technologies Inc. 0.70% 125,000 $230K No change

Portfolio Sells Q1 2024 → Q2 2024
AFRM Affirm Holdings Inc. Reduce -36.2% 95.61% −0.84

Portfolio Buys Q1 2024 → Q2 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q4 2025 1$7.0MBMNR
Q3 2025 3$75.3MFIG, BMNR, ETHZILLA CORPORATION
Q2 2025 1$66KOPEN
Q1 2025 1$128KOPEN
Q4 2024 1$200KOPEN
Q3 2024Amended 2$1.1MAFRM, OPEN
Q2 2024 3$32.7MAFRM, ABCL, OPEN
Q1 2024 3$62.7MAFRM, ABCL, OPEN